Evidence map›Paper›PMID 39777092›Full record

ArticleAging medicine (Milton (N.S.W))2024

Predictive, preventive and personalized project of vascular cognitive impairment in China (P3): Study design and interim baseline patient characteristics of a Nationwide multicenter prospective registry.

Linlin Wang, Jiwei Jiang, Yanli Wang, Gaifen Liu, Wenyi Li, Qiwei Ren, Shirui Jiang, Min Zhao, Huiying Zhang, Tianlin Jiang and 4 more

Abstract read
In one paragraph

Article in Aging medicine (Milton (N.S.W)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Linlin WangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.ORCID https://orcid.org/0000-0001-7901-6715
Jiwei JiangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Yanli WangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Gaifen LiuDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Wenyi LiDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Qiwei RenDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Shirui JiangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Min ZhaoDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Huiying ZhangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Tianlin JiangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Shiyi YangDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
Mei CuiDepartment of Neurology, Huashan Hospital Fudan University Shanghai China.
Qiang DongDepartment of Neurology, Huashan Hospital Fudan University Shanghai China.
Jun XuDepartment of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To outline the design of the P3 study and serve as a summary of the interim baseline patient characteristics. Methods: P3 study is a multicenter, prospective cohort study targeting 1000 acute ischemic stroke (AIS) and cerebral small vessel disease (CSVD) patients with a 2-year follow-up from 80 participating hospitals across China. Comprehensive multimodal imaging, neuropsychological tests, and biological samples were collected prospectively on admission and follow-up visits. Patients were interviewed face to face for 2 years and followed up. Results: Until 30 December 2023, 642 patients were enrolled from 67 centers. In the AIS cohort, 219 patients (72.5%) were diagnosed with acute post-stroke cognitive impairment (PSCI). Compared to those without PSCI, the acute PSCI group exhibited significantly lower levels of education and a history of stroke (all Conclusions: P3 study aims to establish a comprehensive spatiotemporal profile of VCI. Through multidimensional analysis of clinical information, radiomics, proteomics, metabolomics, microbiomics, and genetics, provide a more comprehensive understanding of VCI trajectories and individual variability, enhancing early detection and prognosis management.

Indexed as

Cohort studymultimodal imaging;Arterial spin labelingvascular cognitive impairment

Identifiers

PMID39777092
PMCPMC11702399

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.